|     
              Chicago Journal 
             Lab limbo 
            The current administration’s preference for 
              competition means the University must bid on Argonne National Laboratory. 
            After decades of running the nation’s first 
              national laboratory, Argonne—chartered in 1946 as an outgrowth 
              of Enrico Fermi’s Manhattan Project work—the University 
              now must compete for the job. The 2004 energy and water appropriations 
              legislation, signed by President Bush in December, requires Energy 
              Secretary Spencer Abraham to solicit proposals for lab contracts 
              that haven’t been up for bid in more than 50 years. 
            
              
                  | 
               
              
                | An aerial view of Argonne National 
                  Lab, which comprises 1,700 wooded acres 25 miles southwest of 
                  Chicago. | 
               
             
            In late January the Department of Energy (DOE) 
              formally announced plans to open competition on Argonne and four 
              other labs—Ames National Laboratory, operated by Iowa State 
              University, and three run by the University of California: Lawrence 
              Berkeley, Lawrence Livermore, and Los Alamos. At that time the DOE 
              hadn’t yet issued requests for proposals for those labs—or 
              for Argonne’s sister lab, Idaho’s Argonne West, which 
              the University has operated since its 1949 inception. Argonne West, 
              the department said in April 2003, would be combined with the Idaho 
              National Engineering and Environmental Laboratory. The resulting 
              institution, renamed Idaho National Laboratory, will focus on “developing 
              advanced nuclear energy technologies and other ways of responding 
              to the nation’s future energy and national security requirements,” 
              according to a DOE news release.  
             Chicago plans to compete for both contracts, 
              says Thomas F. Rosenbaum, vice president for Argonne, assuming the 
              solicitations include “a strong science component.” 
              Preparing the proposals, he predicts, could cost “millions 
              of dollars” in staff hours, paperwork, and out-of-town meetings, 
              but maintaining the link to the labs, which are “woven into 
              the intellectual fabric of the University,” warrants an aggressive 
              approach. “We’ll do it because of our responsibilities 
              to the science,” says Rosenbaum, who also oversees University 
              research—although, he says, pitting Chicago, a nonprofit, 
              against potential corporate bidders creates “an asymmetric 
              system.” 
             But competition, asymmetric or not, is the government’s 
              aim. As the San Francisco Chronicle declared in a December 
              article about the University of California’s possible three-lab 
              loss: “The effort to force competition for the management 
              of the labs is part of a larger government-wide agenda by the Bush 
              administration to require high-stakes competitions for many contracts 
              and services.” The Chronicle also noted that Los 
              Alamos’s recent fraud allegations, theft scandals, and management 
              failures compromised the lab’s security. Such missteps, Abraham 
              told the Associated Press in December, is one reason “we found 
              it appropriate to go ahead with competition.” 
             The “much-publicized troubles of the University 
              of California,” Rosenbaum admits, “have not helped” 
              Chicago’s situation, increasing political pressure for “competition 
              for the sake of competition” and “besmirching the reputations 
              of universities” as competent lab managers. “We’re 
              in a performance-based contract,” he notes, and have received 
              stellar yearly performance reviews from the DOE. In both the management 
              and the science and technology categories Chicago has earned mostly 
              “outstanding” ratings—the highest possible—and 
              a few “excellents,” garnering close to the $3 million 
              maximum operating fees in each of the last three years.  
             Of those fees, the University reinvests $370,000, 
              often in joint research projects involving Chicago faculty and Argonne 
              scientists. “Unlike a for-profit that would take the fees 
              for shareholder desires,” Rosenbaum explains, “our return 
              on investment is the intellectual capital that we create.” 
              Such collaboration has fostered both “scientific accomplishment 
              and practical applications,” he says, helping the University 
              to “keep, retain, and attract some of the best people in the 
              world.” 
             Chicago’s scientific goals, Rosenbaum 
              adds, coincide with Idaho National Lab’s expressed mission 
              involving energy policy. “We’re about such big problems; 
              we want to be a part of it.” It’s also a matter of tradition, 
              he says, noting that President Don Michael Randel expressed this 
              view in the October/03 Magazine: “Perhaps because we attended 
              its birth,” Randel wrote, “we have a particular responsibility 
              in relation to nuclear energy. Perhaps also we have a moral responsibility 
              to bear our values on an important and complicated set of issues.” 
             
             To compete for the Illinois and Idaho contracts 
              the University may follow the models that won it two grants last 
              September: $35 million for Argonne to become a Regional Center of 
              Excellence for Biodefense and Emerging Infectious Diseases Research 
              and $17 million to build a Regional Biocontainment Laboratory there. 
              Having a secure, well-equipped site and strong intellectual-science 
              resources, Rosenbaum says, helped the University to win those bids. 
             
             This time Chicago also may seek a partner, perhaps 
              a company with strong management experience. Officials are already 
              talking with some businesses about teaming up for the Idaho contract, 
              but for the Chicago bid, Rosenbaum says, “we prefer to do 
              it ourselves.” 
             Although Argonne’s current contract expires 
              in September, the delayed appearance of the proposal requests—which 
              may not be published until this summer, some observers say—could 
              mean that the DOE won’t decide on a bidder until after the 
              November elections.—A.M.B. 
             
                
             | 
            |